These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4940644)

  • 41. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.
    Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK
    Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
    Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
    Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Sensitivity of the protection test in guinea pigs vaccinated by BCG. I. Influence of age or slight viability margins of BCG cultures].
    Frappier A; Portelance V; Marois P; St-Pierre J
    Ann Inst Pasteur (Paris); 1967 Sep; 113(3):425-47. PubMed ID: 4860409
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparison of the in vivo multiplication of 10 BCG substrains in three strains of mice: no correlation with their antitumour activity.
    Frenette M; Portelance V; Beaudet R
    Microbios; 1983; 36(145-46):173-82. PubMed ID: 6346021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccination of white-tailed deer (Odocoileus virginianus) with Mycobacterium bovis bacillus Calmette Guerín.
    Palmer MV; Thacker TC; Waters WR
    Vaccine; 2007 Sep; 25(36):6589-97. PubMed ID: 17688976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [30 Years of BCG-vaccination in GDR - 30 years of BCG-vaccine production in Jena].
    Zureck A
    Z Erkr Atmungsorgane; 1982; 158(1-2):168-84. PubMed ID: 7041443
    [No Abstract]   [Full Text] [Related]  

  • 47. [Sealing of lyophilized BCG in argon and its advantages].
    Sturdza SA; Gheorghiu M; Rîmniceanu I
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):57-65. PubMed ID: 4936245
    [No Abstract]   [Full Text] [Related]  

  • 48. Changes in BCG strains.
    Osborn TW
    Tubercle; 1983 Mar; 64(1):1-13. PubMed ID: 6342243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potency of 10 BCG vaccines as evaluated by their influence on the bacillemic phase of experimental airborne tuberculosis in guinea-pigs.
    Smith D; Harding G; Chan J; Edwards M; Hank J; Muller D; Sobhi F
    J Biol Stand; 1979 Jul; 7(3):179-97. PubMed ID: 387796
    [No Abstract]   [Full Text] [Related]  

  • 50. [Data on BCG variability].
    Paraschivescu M; Gheorghiu M; Miron S; Bonciu C; Petroviei M; Rîmniceanu I
    Microbiol Parazitol Epidemiol (Bucur); 1970; 15(4):353-8. PubMed ID: 4917264
    [No Abstract]   [Full Text] [Related]  

  • 51. Standardization of BCG multiple puncture 40 mg and BCG live (intravesical) Theracys/BCG therapeutic Immucyst.
    Csizer Z; Herbert A; Guest N; Sparkes J; Barreto L; Harjee N; Langlois S
    Dev Biol Stand; 1992; 77():223-7. PubMed ID: 1426666
    [No Abstract]   [Full Text] [Related]  

  • 52. In vitro drug susceptibility of Mycobacterium bovis BCG Connaught and Tokyo strains.
    Shimizu T; Yasumoto K; Tatano Y; Tomioka H; Sato K; Sano C; Kumon H; Monden K
    J Infect; 2010 Mar; 60(3):248-51. PubMed ID: 20074586
    [No Abstract]   [Full Text] [Related]  

  • 53. The residual virulence of the Rumanian strain of B.C.G.
    Drăghici D; Andronescu F; Olinescu E; Georgescu L; Bordasiu R
    Arch Roum Pathol Exp Microbiol; 1974; 33(3-4):261-6. PubMed ID: 4619553
    [No Abstract]   [Full Text] [Related]  

  • 54. An interlaboratory comparative assay of viability and heat stability control of different BCG vaccines on two solid culture media.
    Suire A; Gheorghiu M
    Dev Biol Stand; 1986; 58 ( Pt A)():155-62. PubMed ID: 3297861
    [No Abstract]   [Full Text] [Related]  

  • 55. Electron microscopy study of the size of cells of tuberculosis vaccine strains.
    Sula L; Mohelská H; Makovcová A; Svandová E
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(1):107-14. PubMed ID: 4886936
    [No Abstract]   [Full Text] [Related]  

  • 56. Long-term stability of BCG vaccine sealed in ampoules under nitrogen with reference to its short-term heat resistance.
    Freudenstein H
    Dev Biol Stand; 1986; 58 ( Pt A)():133-7. PubMed ID: 3297859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Virulence of six strains of Mycobacterium bovis (BCG) in mice.
    Sher NA; Chaparas SD; Pearson J; Chirigos M
    Infect Immun; 1973 Nov; 8(5):736-42. PubMed ID: 4584050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Multiplication of lyophilized BCG in the body of the white mouse].
    Drăghici D; Sturdza SA; Gheorghiu M; Iliescu A
    Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):745-8. PubMed ID: 4939334
    [No Abstract]   [Full Text] [Related]  

  • 59. Asparaginase activity of BCG and its phenotypes in relation to culture phases.
    Turcotte R; Quevillon M
    Ann Microbiol (Paris); 1975 Sep; 126(2):181-5. PubMed ID: 766691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Current biological problems concerning B.C.G. vaccine].
    Carnus H
    Rev Corps Sante Armees Terre Mer Air; 1972 Apr; 13(2):165-80. PubMed ID: 4263334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.